NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
+125% earnings on previous quarter, average growth of +30% previous quarters
+76% revenue growth, accelerating from previous quarters
+44% net margins, expanding from +30%
Positive earnings revisions

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。